These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 32859254)
1. Predictive value of neutrophil to lymphocyte and platelet to lymphocyte ratio in COVID-19. Zhu S; Dong L; Cai W Crit Care; 2020 Aug; 24(1):532. PubMed ID: 32859254 [No Abstract] [Full Text] [Related]
2. High neutrophil to lymphocyte ratio as a prognostic marker in COVID-19 patients. Pimentel GD; Dela Vega MCM; Laviano A Clin Nutr ESPEN; 2020 Dec; 40():101-102. PubMed ID: 33183520 [TBL] [Abstract][Full Text] [Related]
3. Using the neutrophil-to-lymphocyte ratio to estimate the severity of coronavirus disease 2019. Kotani K; Morisawa Y; Yamada T Pol Arch Intern Med; 2020 Aug; 130(7-8):716-717. PubMed ID: 32852911 [No Abstract] [Full Text] [Related]
4. Using the neutrophil-to-lymphocyte ratio to estimate the severity of coronavirus disease 2019. Authors' reply. Ye L; Zeng F; Du S; Deng G Pol Arch Intern Med; 2020 Aug; 130(7-8):717-718. PubMed ID: 32852912 [No Abstract] [Full Text] [Related]
5. Ratios of neutrophil-to-lymphocyte and platelet-to-lymphocyte predict all-cause mortality in inpatients with coronavirus disease 2019 (COVID-19): a retrospective cohort study in a single medical centre. Wang X; Li X; Shang Y; Wang J; Zhang X; Su D; Zhao S; Wang Q; Liu L; Li Y; Chen H Epidemiol Infect; 2020 Sep; 148():e211. PubMed ID: 32900409 [TBL] [Abstract][Full Text] [Related]
6. Rationale Use of Neutrophil-to-lymphocyte ratio for early diagnosis and stratification of COVID-19. Zahorec R; Hulin I; Zahorec P Bratisl Lek Listy; 2020; 121(7):466-470. PubMed ID: 32989997 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of Acute Respiratory Distress Syndrome in COVID-19: "Typical" or Not? Maley JH; Winkler T; Hardin CC Am J Respir Crit Care Med; 2020 Aug; 202(4):618-619. PubMed ID: 32579019 [No Abstract] [Full Text] [Related]
8. Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): A multicenter, cross-sectional study. Peng J; Qi D; Yuan G; Deng X; Mei Y; Feng L; Wang D J Clin Lab Anal; 2020 Oct; 34(10):e23475. PubMed ID: 32681559 [TBL] [Abstract][Full Text] [Related]
9. Covid-19, Angiogenesis, and ARDS Endotypes. Hariri L; Hardin CC N Engl J Med; 2020 Jul; 383(2):182-183. PubMed ID: 32437597 [No Abstract] [Full Text] [Related]
10. Neutrophil-to-lymphocyte ratio predicts the clearance of SARS-CoV-2 RNA in mild COVID-19 patients - a retrospective analysis from Dongxihu Fangcang Hospital in Wuhan, China. Zhu C; Yu S; Zhao H; Shen H; Yang J; Zhao L; Wu W Clin Chem Lab Med; 2020 Aug; 58(9):e167-e170. PubMed ID: 32609644 [No Abstract] [Full Text] [Related]
11. Inhibiting IL-6 in COVID-19: we are not sure. Honore PM; Barreto Gutierrez L; Kugener L; Redant S; Attou R; Gallerani A; De Bels D Crit Care; 2020 Jul; 24(1):463. PubMed ID: 32718345 [No Abstract] [Full Text] [Related]
12. Treatment of COVID-19 by Inhaled NO to Reduce Shunt? Hedenstierna G; Chen L; Hedenstierna M; Scaramuzzo G Am J Respir Crit Care Med; 2020 Aug; 202(4):618. PubMed ID: 32579020 [No Abstract] [Full Text] [Related]
13. Extracorporeal membrane oxygenation for acute respiratory distress syndrome in patients with coronavirus disease 2019: what do we know so far? Burgos LM; Seoane L; Diez M Perfusion; 2020 Sep; 35(6):558-561. PubMed ID: 32579068 [No Abstract] [Full Text] [Related]
14. Association between NLR and COVID-19. Kalemci S; Sarıhan A; Zeybek A Int Immunopharmacol; 2020 Nov; 88():106917. PubMed ID: 32889243 [No Abstract] [Full Text] [Related]
15. Severe Covid-19 disease: rather AVDS than ARDS? Mahjoub Y; Rodenstein DO; Jounieaux V Crit Care; 2020 Jun; 24(1):327. PubMed ID: 32527297 [No Abstract] [Full Text] [Related]
16. Lung Mechanics in COVID-19 Resemble Respiratory Distress Syndrome, Not Acute Respiratory Distress Syndrome: Could Surfactant Be a Treatment? Koumbourlis AC; Motoyama EK Am J Respir Crit Care Med; 2020 Aug; 202(4):624-626. PubMed ID: 32579022 [No Abstract] [Full Text] [Related]
17. Risk of peripheral arterial thrombosis in COVID-19. Mestres G; Puigmacià R; Blanco C; Yugueros X; Esturrica M; Riambau V J Vasc Surg; 2020 Aug; 72(2):756-757. PubMed ID: 32417015 [No Abstract] [Full Text] [Related]
18. COVID-19: Respiratory support outside the intensive care unit. McEnery T; Gough C; Costello RW Lancet Respir Med; 2020 Jun; 8(6):538-539. PubMed ID: 32278367 [No Abstract] [Full Text] [Related]
19. COVID-19 Lung Injury and "Typical" Acute Respiratory Distress Syndrome: The Danger of Presumed Equivalency. Kyle-Sidell C Ann Am Thorac Soc; 2020 Sep; 17(9):1171-1172. PubMed ID: 32432895 [No Abstract] [Full Text] [Related]
20. Does Coronavirus Disease 2019 Disprove the Obesity Paradox in Acute Respiratory Distress Syndrome? Jose RJ; Manuel A Obesity (Silver Spring); 2020 Jun; 28(6):1007. PubMed ID: 32294322 [No Abstract] [Full Text] [Related] [Next] [New Search]